CIBC Bancorp USA’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
CIBC Bancorp USA's EXEL Position: Q3 2026 in Review
CIBC Bancorp USA increased its Exelixis (EXEL) stake by 10% in Q3 2026, buying an estimated $41.5K and bringing the position to 7,987 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.
CIBC Bancorp USA first reported a position in EXEL in Q1 2026 and has held it in 3 quarters since. 637 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.
- CIBC Bancorp USA held 7,987 shares of Exelixis worth $467K as of Q3 2026.
- CIBC Bancorp USA bought 745 Exelixis shares in Q3 2026, an estimated $41.5K.
- Exelixis made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1414 holding.
- CIBC Bancorp USA first reported a position in Exelixis in Q1 2026 and has held it in 3 quarters since.
- 637 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.